Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018.
- DOI
- 10.1136/bmjsit-2022-000152
- Published
- 2023
- Container
- BMJ surgery, interventions, & health technologies
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjsit-2022-000152,
title = {Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018.},
author = {Rathi VK and Johnston JL and Dhruva S and Ross J},
year = {2023},
journal = {BMJ surgery, interventions, \& health technologies},
doi = {10.1136/bmjsit-2022-000152},
url = {https://doi.org/10.1136/bmjsit-2022-000152}
}RIS
TY - JOUR TI - Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018. AU - Rathi VK AU - Johnston JL AU - Dhruva S AU - Ross J PY - 2023 JO - BMJ surgery, interventions, & health technologies DO - 10.1136/bmjsit-2022-000152 UR - https://doi.org/10.1136/bmjsit-2022-000152 ER -
APA
VK, R., JL, J., S, D., & J, R. (2023). Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018.. BMJ surgery, interventions, & health technologies. https://doi.org/10.1136/bmjsit-2022-000152
Source records
- pubmed · retrieved 2026-09-26T10:37:00.704Z